Review

np ova (Biosearch Technologies Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Biosearch Technologies Inc np ova

Immunization experiment scheme for in vivo screen Host mice (IOMA gl) were immunized <t>with</t> <t>OVA</t> in alum. At week 2 after immunization, B cells from B1-8 hi , LSL-Cas9, AID-Cre, Kappa KO animals were transduced with pooled sgRNA library retrovirus and adoptively transferred to the hosts. Subsequently, the host animals were boosted <t>with</t> <t>NP-OVA</t> in alum at day 0 and 2 and administered with anti-DEC205-OVA mAb at day 6.5. Spleens were harvested and processed for cell sorting at day 10.

Np Ova, supplied by Biosearch Technologies Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/np+ova/np+ova/pmc13199673-27-0-5
Average 86 stars, based on 1 article reviews

np ova - by Bioz Stars, 2026-11

86/100 stars

Images

1) Product Images from "Protocol for an in vivo CRISPR screen for germinal center B cells in mice using ecotropic retrovirus"

Article Title: Protocol for an in vivo CRISPR screen for germinal center B cells in mice using ecotropic retrovirus

Journal: STAR Protocols

doi: 10.1016/j.xpro.2026.104586

Immunization experiment scheme for in vivo screen Host mice (IOMA gl) were immunized with OVA in alum. At week 2 after immunization, B cells from B1-8 hi , LSL-Cas9, AID-Cre, Kappa KO animals were transduced with pooled sgRNA library retrovirus and adoptively transferred to the hosts. Subsequently, the host animals were boosted with NP-OVA in alum at day 0 and 2 and administered with anti-DEC205-OVA mAb at day 6.5. Spleens were harvested and processed for cell sorting at day 10.

Figure Legend Snippet: Immunization experiment scheme for in vivo screen Host mice (IOMA gl) were immunized with OVA in alum. At week 2 after immunization, B cells from B1-8 hi , LSL-Cas9, AID-Cre, Kappa KO animals were transduced with pooled sgRNA library retrovirus and adoptively transferred to the hosts. Subsequently, the host animals were boosted with NP-OVA in alum at day 0 and 2 and administered with anti-DEC205-OVA mAb at day 6.5. Spleens were harvested and processed for cell sorting at day 10.

Techniques Used: In Vivo, Transduction, FACS

other:

Article Title: B cell expression of an enzymatic intermediary in ether lipid biosynthesis promotes antibody responses and germinal center size
Article Snippet: Monoclonal antibodies (mAb) against mouse CD40, CD90.2, B220 (CD45R), and other mAbs (purified, biotinylated, or fluorophore- conjugated) were from BD Biosciences or Tonbo Biosciences (San Diego CA) unless otherwise indicated.

Article Title: Sequential class switching generates antigen-specific gut IgA from IgG1 B cells
Article Snippet: GL7 (GL7) , Biolegend , Cat#144606; Cat#144610.

Enzyme-linked Immunosorbent Assay:

Article Title: B cell expression of an enzymatic intermediary in ether lipid biosynthesis promotes antibody responses and germinal center size
Article Snippet: Tamoxifen (Tmx) was from APExBio Technology (Houston TX). .. NP-BSA and NP-PSA (for capture in ELISA) as well as NP-OVA (for immunization) were obtained from Biosearch Technology (Novato, CA). .. SRBCs (sheep red blood cells) were from Thermo Fisher Scientific (Waltham, MA).

Conjugation Assay:

Article Title: Protocol for an in vivo CRISPR screen for germinal center B cells in mice using ecotropic retrovirus
Article Snippet: OVA , Biosearch Technologies , cat# O-1000. .. NP-OVA (conjugation ratio: 21) , Biosearch Technologies , cat# N-5051. .. Opti-ME I Reduced Serum Medium, GlutaMAX Supplement , Gibco , cat# 51985034.

Article Title: B lymphocytes that enter the germinal center late preferentially differentiate into memory cells that recognize subdominant epitopes.
Article Snippet: .. Immunizations were performed at the footpad with 50 uL of PBS containing 25 ug of NP-OVA (Biosearch technologies, NP conjugation ratio 17) precipitated in aluminum hydroxide gel adjuvant (Alhydrogel, Invivogen, vac-alu-250) at a 2:1 ratio. .. 2, 3 and 4 μg of SARS-CoV-2 RBD were used to immunize the mice in an escalating dose format on day 1, 3 and 5, with Alhydrogel adjuvant only accompanying the protein on the first injection.

Adjuvant:

Article Title: Stability and progressive differentiation of T FR cells are intrinsically and extrinsically controlled by T FH programs.
Article Snippet: .. Mice were immunized with 100 μg NP-OVA (Biosearch Technologies) emulsified (1:1) in complete Freund adjuvant (CFA, Sigma-Aldrich) for subcutaneous immunization or emulsified in incomplete Freund adjuvant (IFA, Sigma-Aldrich) for intraperitoneal immunization. ..

Article Title: Oral tributyrin supplementation induces Treg-mediated immune regulation and prolongs allograft survival in preclinical transplant models.
Article Snippet: .. On day 7 of treatment, mice were 168 immunized subcutaneously with 200 μg of Np-OVA (Biosearch Technologies) emulsified in 169 complete Freund’s adjuvant (Thermo Fisher Scientific). ..

Article Title: Stability and progressive differentiation of T FR cells are intrinsically and extrinsically controlled by T FH programs
Article Snippet: .. Mice were immunized with 100 μg NP-OVA (Biosearch Technologies) emulsified (1:1) in complete Freund adjuvant (CFA, Sigma-Aldrich) for subcutaneous immunization or emulsified in incomplete Freund adjuvant (IFA, Sigma-Aldrich) for intraperitoneal immunization. ..

Mouse Assay:

Immunofluorescence:

Image Search Results

Journal: STAR Protocols

Article Title: Protocol for an in vivo CRISPR screen for germinal center B cells in mice using ecotropic retrovirus

doi: 10.1016/j.xpro.2026.104586

Figure Lengend Snippet: Immunization experiment scheme for in vivo screen Host mice (IOMA gl) were immunized with OVA in alum. At week 2 after immunization, B cells from B1-8 hi , LSL-Cas9, AID-Cre, Kappa KO animals were transduced with pooled sgRNA library retrovirus and adoptively transferred to the hosts. Subsequently, the host animals were boosted with NP-OVA in alum at day 0 and 2 and administered with anti-DEC205-OVA mAb at day 6.5. Spleens were harvested and processed for cell sorting at day 10.

Article Snippet: NP-OVA (conjugation ratio: 21) , Biosearch Technologies , cat# N-5051.

Techniques: In Vivo, Transduction, FACS

( A ) Breeding scheme for generating CNS1-YFP-RFP OT-II Tg mice. Foxp3 ΔCNS1-Cre-Thy1.1 (expressing Cre under the Foxp3 promoter with CNS1 deleted) were crossed with Rosa26 loxP-stop-loxP-YFP and Foxp3 IRES-RFP mice. Cre-mediated excision of the loxP-flanked stop cassette at the Rosa26 locus enables YFP expression, while RFP reports Foxp3 expression. CNS1-YFP-RFP mice were further crossed with OT-II TCR transgenic mice (specific for OVA 323–339 ). ( B ) Experimental setup for adoptive transfer and immunization. CD45.1 + CD45.2 + CD4 + YFP + RFP + OT-II Tg tT reg cells were transferred intravenously into CD45.2 + recipients. One day later, mice were immunized intraperitoneally with PBS or NP-OVA plus alum. Spleens were analyzed by flow cytometry on day 7. ( C ) TCR stimulation influences tT reg cells stability. (left) Flow cytometry plots showing Thy1.1 and Foxp3 expression in CD4 + YFP + tT reg cells from PBS (n=4) or NP-OVA plus alum (n=9) immunized recipient spleens. Numbers indicate gate frequencies. (right) Quantification of ex-T reg cells (Foxp3 − Thy1.1 − , red box). ( D ) Altered peptide ligands (APLs) with varying TCR affinities. OVA-derived APLs are shown with OT-II TCR-binding regions highlighted: OVA 323–339 (red), OVA 327–339 (orange), OVA 328–339 (purple), and OVA 329–339 (blue). Affinity decreases sequentially. ( E ) Frequency of transferred OT-II Tg T reg cells in recipient mice. Proportion of CD45.1 + CD45.2 + OT-II Tg T reg cells among total CD4 + cells after immunization with indicated OVA peptides plus alum. ( F ) Ex-tT reg cells generation correlates with TCR signal strength. Frequency of Foxp3 − Thy1.1 − ex-tT reg cells among activated CD4 + CD44 + YFP + cells after peptide immunization. ( G ) Intense TCR signals drive T FR cells instability. Representative flow cytometry plots showing T FR cells differentiation and ex-tT reg cells generation following high-affinity TCR stimulation. ND means not displayed due to being below the detection limit. (E) to (G) show pooled data from two independent experiments with OVA 323–339 (n=7), OVA 327–339 (n=5), OVA 328–339 (n=4), and OVA 329–339 (n=4). All flow cytometry data were acquired from two independent experiments. Error bars show mean ± SD. P values were calculated using the unpaired Student’s t -test. ** P <0.01.

Journal: bioRxiv

Article Title: TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

doi: 10.64898/2026.02.12.705537

Figure Lengend Snippet: ( A ) Breeding scheme for generating CNS1-YFP-RFP OT-II Tg mice. Foxp3 ΔCNS1-Cre-Thy1.1 (expressing Cre under the Foxp3 promoter with CNS1 deleted) were crossed with Rosa26 loxP-stop-loxP-YFP and Foxp3 IRES-RFP mice. Cre-mediated excision of the loxP-flanked stop cassette at the Rosa26 locus enables YFP expression, while RFP reports Foxp3 expression. CNS1-YFP-RFP mice were further crossed with OT-II TCR transgenic mice (specific for OVA 323–339 ). ( B ) Experimental setup for adoptive transfer and immunization. CD45.1 + CD45.2 + CD4 + YFP + RFP + OT-II Tg tT reg cells were transferred intravenously into CD45.2 + recipients. One day later, mice were immunized intraperitoneally with PBS or NP-OVA plus alum. Spleens were analyzed by flow cytometry on day 7. ( C ) TCR stimulation influences tT reg cells stability. (left) Flow cytometry plots showing Thy1.1 and Foxp3 expression in CD4 + YFP + tT reg cells from PBS (n=4) or NP-OVA plus alum (n=9) immunized recipient spleens. Numbers indicate gate frequencies. (right) Quantification of ex-T reg cells (Foxp3 − Thy1.1 − , red box). ( D ) Altered peptide ligands (APLs) with varying TCR affinities. OVA-derived APLs are shown with OT-II TCR-binding regions highlighted: OVA 323–339 (red), OVA 327–339 (orange), OVA 328–339 (purple), and OVA 329–339 (blue). Affinity decreases sequentially. ( E ) Frequency of transferred OT-II Tg T reg cells in recipient mice. Proportion of CD45.1 + CD45.2 + OT-II Tg T reg cells among total CD4 + cells after immunization with indicated OVA peptides plus alum. ( F ) Ex-tT reg cells generation correlates with TCR signal strength. Frequency of Foxp3 − Thy1.1 − ex-tT reg cells among activated CD4 + CD44 + YFP + cells after peptide immunization. ( G ) Intense TCR signals drive T FR cells instability. Representative flow cytometry plots showing T FR cells differentiation and ex-tT reg cells generation following high-affinity TCR stimulation. ND means not displayed due to being below the detection limit. (E) to (G) show pooled data from two independent experiments with OVA 323–339 (n=7), OVA 327–339 (n=5), OVA 328–339 (n=4), and OVA 329–339 (n=4). All flow cytometry data were acquired from two independent experiments. Error bars show mean ± SD. P values were calculated using the unpaired Student’s t -test. ** P <0.01.

Article Snippet: For footpad immunization, mice received 10 μg of alum-precipitated NP-OVA (Biosearch Technologies) as previously described ( ).

Techniques: Expressing, Transgenic Assay, Adoptive Transfer Assay, Flow Cytometry, Derivative Assay, Binding Assay

( A ) Immunization and analysis scheme. CNS1-YFP-RFP mice received footpad injections of 10 μg NP-OVA plus alum. Draining popliteal lymph nodes (dpoLNs) and non-draining popliteal lymph nodes(ndpoLNs) were analyzed by flow cytometry for PD-1 and CXCR5 expression on CD4 + YFP + tT reg cells at indicated time points. ( B ) T FR differentiation kinetics. (left) Representative flow plots of PD-1 versus CXCR5 on CD4 + CD44 + YFP + tT reg cells. (right) Quantification of T FR cell frequency (top) and numbers (bottom) in dpoLNs versus ndpoLNs. Day4 (n=3), day7 (n=5), day10 (n=4), day14 (n=3), day21(n=2). Flow cytometry data were acquired from two independent experiments. ( C ) scRNA-seq experimental design. PD-1 + CXCR5 + YFP + T FR cells from immunized mice were FACS-sorted for single-cell RNA and TCR sequencing. ( D ) T FR cell subsets heterogeneity. UMAP projection of 7 transcriptionally distinct clusters. Dot plot shows relative expression of Foxp3, Pdcd1 (PD-1), and Cxcr5 (red: high; gray: low). ( E ) Developmental regulation of CD25. Il2ra (CD25) expression patterns in early-(C3/C5/C6) versus late-stage (C1/C2/C4) T FR cell clusters. ( F ) Ex-T reg cytokine production. Il21 expression map showing Foxp3 - Il21 + cells (purple) within late-stage T FR cell clusters. ( G ) TCR clonal analysis. Six expanded clonotypes (colored) with corresponding CDR3α/β sequences. ( H ) TCR signaling assay. Schematic of NFAT-GFP reporter system in TCR-transduced hybridomas cultured with APCs plus antigen/LPS. ( I ) Antigen specificity validation. GFP induction in OTREG-1 hybridomas stimulated with OVA peptide variants. Representative flow cytometry data of four independent experiment(left). Each data point represents one independent experiment. ( J ) Tetramer reagents. Designed OVA peptide sequences (OVA 302-316 , OVA 303-313 , OVA 304-314 ) for TCR specificity testing. ( K ) Tetramer binding confirmation. Flow cytometry analysis of TCRβ versus OVA-tetramer staining (control: hCLIP 87-101 tetramer).

Journal: bioRxiv

Article Title: TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

doi: 10.64898/2026.02.12.705537

Figure Lengend Snippet: ( A ) Immunization and analysis scheme. CNS1-YFP-RFP mice received footpad injections of 10 μg NP-OVA plus alum. Draining popliteal lymph nodes (dpoLNs) and non-draining popliteal lymph nodes(ndpoLNs) were analyzed by flow cytometry for PD-1 and CXCR5 expression on CD4 + YFP + tT reg cells at indicated time points. ( B ) T FR differentiation kinetics. (left) Representative flow plots of PD-1 versus CXCR5 on CD4 + CD44 + YFP + tT reg cells. (right) Quantification of T FR cell frequency (top) and numbers (bottom) in dpoLNs versus ndpoLNs. Day4 (n=3), day7 (n=5), day10 (n=4), day14 (n=3), day21(n=2). Flow cytometry data were acquired from two independent experiments. ( C ) scRNA-seq experimental design. PD-1 + CXCR5 + YFP + T FR cells from immunized mice were FACS-sorted for single-cell RNA and TCR sequencing. ( D ) T FR cell subsets heterogeneity. UMAP projection of 7 transcriptionally distinct clusters. Dot plot shows relative expression of Foxp3, Pdcd1 (PD-1), and Cxcr5 (red: high; gray: low). ( E ) Developmental regulation of CD25. Il2ra (CD25) expression patterns in early-(C3/C5/C6) versus late-stage (C1/C2/C4) T FR cell clusters. ( F ) Ex-T reg cytokine production. Il21 expression map showing Foxp3 - Il21 + cells (purple) within late-stage T FR cell clusters. ( G ) TCR clonal analysis. Six expanded clonotypes (colored) with corresponding CDR3α/β sequences. ( H ) TCR signaling assay. Schematic of NFAT-GFP reporter system in TCR-transduced hybridomas cultured with APCs plus antigen/LPS. ( I ) Antigen specificity validation. GFP induction in OTREG-1 hybridomas stimulated with OVA peptide variants. Representative flow cytometry data of four independent experiment(left). Each data point represents one independent experiment. ( J ) Tetramer reagents. Designed OVA peptide sequences (OVA 302-316 , OVA 303-313 , OVA 304-314 ) for TCR specificity testing. ( K ) Tetramer binding confirmation. Flow cytometry analysis of TCRβ versus OVA-tetramer staining (control: hCLIP 87-101 tetramer).

Article Snippet: For footpad immunization, mice received 10 μg of alum-precipitated NP-OVA (Biosearch Technologies) as previously described ( ).

Techniques: Flow Cytometry, Expressing, Single Cell, Sequencing, Cell Culture, Biomarker Discovery, Binding Assay, Staining, Control

( A ) Kinetics of T FH cell differentiation post-immunization. (left) Flow cytometry plots showing PD-1 and CXCR5 expression on CD4 + CD44 + YFP - RFP - T FH cells in draining and non-draining popliteal lymph nodes (dpoLNs and ndpoLNs) at indicated time points. (right) Quantification of T FH cell frequency (top) and absolute cell numbers (bottom). Day4 (n=3), day7 (n=5), day10 (n=4), day14 (n=3), day21(n=2). Flow cytometry data were acquired from two independent experiments. ( B ) Transcriptional signatures of T FR clusters. Heatmap of differentially expressed genes (DEGs) across Tfr cell clusters (C1–C7). ( C ) Consensus gene signatures of late-stage T FR cells. Venn diagram comparing DEGs between: Late-stage (C1/C2/C4) versus early-stage (C3/C5/C6) T FR cell clusters; CD25 − versus CD25 + T FR cells ( D ) Antigen-specific TCR activation assay. GFP induction in hybridomas expressing six expanded TCR clonotypes (OTREG-1, TCR2–6) after 48 h co-culture with: NP-OVA plus APCs (positive conditions), NP-OVA without APCs and NP-BSA or medium (negative controls). Representative flow cytometry data of two independent experiment. ( E ) UMAP highlighting the dominant OTREG-1 TCR clone with Il21 expression.

Journal: bioRxiv

Article Title: TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

doi: 10.64898/2026.02.12.705537

Figure Lengend Snippet: ( A ) Kinetics of T FH cell differentiation post-immunization. (left) Flow cytometry plots showing PD-1 and CXCR5 expression on CD4 + CD44 + YFP - RFP - T FH cells in draining and non-draining popliteal lymph nodes (dpoLNs and ndpoLNs) at indicated time points. (right) Quantification of T FH cell frequency (top) and absolute cell numbers (bottom). Day4 (n=3), day7 (n=5), day10 (n=4), day14 (n=3), day21(n=2). Flow cytometry data were acquired from two independent experiments. ( B ) Transcriptional signatures of T FR clusters. Heatmap of differentially expressed genes (DEGs) across Tfr cell clusters (C1–C7). ( C ) Consensus gene signatures of late-stage T FR cells. Venn diagram comparing DEGs between: Late-stage (C1/C2/C4) versus early-stage (C3/C5/C6) T FR cell clusters; CD25 − versus CD25 + T FR cells ( D ) Antigen-specific TCR activation assay. GFP induction in hybridomas expressing six expanded TCR clonotypes (OTREG-1, TCR2–6) after 48 h co-culture with: NP-OVA plus APCs (positive conditions), NP-OVA without APCs and NP-BSA or medium (negative controls). Representative flow cytometry data of two independent experiment. ( E ) UMAP highlighting the dominant OTREG-1 TCR clone with Il21 expression.

Article Snippet: For footpad immunization, mice received 10 μg of alum-precipitated NP-OVA (Biosearch Technologies) as previously described ( ).

Techniques: Cell Differentiation, Flow Cytometry, Expressing, Activation Assay, Co-Culture Assay

( A ) Predicted OVA peptide affinities. Structural modeling of six OVA-derived peptides ranked by estimated TCR-binding affinity. ( B ) Dose-response to OVA 302-316 peptide. Percentage of GFP + OTREG-1 (purple) and OT-II (orange) hybridoma cells after 48h coculture with indicated concentrations of OVA 302-316 peptide. Data represent mean ± SD of triplicate experiments. ( C ) Dose-response to OVA 323-339 peptide. Percentage of GFP + cells for each hybridoma line cultured with graded doses of OVA 323-339 peptide. Data represent mean ± SD of triplicate experiments. ( D ) Dose-response to NP-OVA. Percentage of GFP + OTREG-1 (purple) and OT-II (orange) hybridoma cells after 48 h coculture with indicated concentrations of NP-OVA. Data represent mean ± SD of triplicate experiments. ( E ) Dose-response to OVA 302-339 . Percentage of GFP + OTREG-1 (purple) and OT-II (orange) hybridoma cells after 48 h coculture with indicated concentrations of OVA 302-339 peptide. Representative flow cytometry data of four independent experiment(left). Error bars show mean ± SD, P values were calculated using multiple unpaired Student’s t -test, **** P <0.0001.

Journal: bioRxiv

Article Title: TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

doi: 10.64898/2026.02.12.705537

Figure Lengend Snippet: ( A ) Predicted OVA peptide affinities. Structural modeling of six OVA-derived peptides ranked by estimated TCR-binding affinity. ( B ) Dose-response to OVA 302-316 peptide. Percentage of GFP + OTREG-1 (purple) and OT-II (orange) hybridoma cells after 48h coculture with indicated concentrations of OVA 302-316 peptide. Data represent mean ± SD of triplicate experiments. ( C ) Dose-response to OVA 323-339 peptide. Percentage of GFP + cells for each hybridoma line cultured with graded doses of OVA 323-339 peptide. Data represent mean ± SD of triplicate experiments. ( D ) Dose-response to NP-OVA. Percentage of GFP + OTREG-1 (purple) and OT-II (orange) hybridoma cells after 48 h coculture with indicated concentrations of NP-OVA. Data represent mean ± SD of triplicate experiments. ( E ) Dose-response to OVA 302-339 . Percentage of GFP + OTREG-1 (purple) and OT-II (orange) hybridoma cells after 48 h coculture with indicated concentrations of OVA 302-339 peptide. Representative flow cytometry data of four independent experiment(left). Error bars show mean ± SD, P values were calculated using multiple unpaired Student’s t -test, **** P <0.0001.

Article Snippet: For footpad immunization, mice received 10 μg of alum-precipitated NP-OVA (Biosearch Technologies) as previously described ( ).

Techniques: Derivative Assay, Binding Assay, Cell Culture, Flow Cytometry

( A ) Altered thymocyte development in OTREG-1 Tg mice. (left) Flow cytometry plots of CD4 and CD8 expression in thymocytes from 4–5-week-old WT and OTREG-1 Tg mice. (right) Quantification of DN (double-negative), DP (double-positive), CD4 SP (single-positive), and CD8 SP populations. Data are pooled from all mice. Female WT(n=9), Male WT(n=10), Female OTREG-1 Tg (n=10), Male OTREG-1 Tg (n=10). ( B ) Impaired thymic maturation of OTREG-1 Tg T cells. (left) CD24 and Qa-2 expression on TCRβ hi CD4 SP thymocytes. (right) Frequency of mature CD24 lo Qa-2 hi cells among TCRβ hi CD4 SP thymocytes. Female WT(n=9), Male WT(n=10), Female OTREG-1 Tg (n=10), Male OTREG-1 Tg (n=10). ( C ) Homeostatic proliferation of OTREG-1 Tg T cells. (left) Histograms showing proliferation (CFSE dilution) of splenic OTREG-1 Tg (n=4) and OT-II Tg (n=4) CD4 + T cells. (right) Quantification of divided cells at day 4 and day 7. ( D ) Competitive proliferation assay design. Naive CD4 + CD25 − CD44 lo CD62 hi T cells from CD45.2 + OTREG-1 Tg and CD45.1 + OT-II Tg mice were mixed 1:1, CFSE-labeled, and transferred into CD45.1 + CD45.2 + WT hosts. Recipients were immunized i.p. with PBS (n=2) or NP-OVA plus alum (n=11); donor cells were analyzed 3 days later. ( E ) Activation of OTREG-1 versus OT-II Tg T cells. Flow cytometry plots of CFSE dilution (proliferation) and CD44 expression in donor CD45.2 + OTREG-1 and CD45.1 + OT-II Tg CD4 + T cells. ( F ) T FH differentiation potential. Flow cytometry plots of PD-1 and CXCR5 expression on donor OTREG-1 and OT-II Tg CD4 + T cells. ( G ) Quantification of activated/proliferating T cells. (upper) Frequency of CFSE lo CD44 hi cells among OTREG-1 (CD45.2 + ) and OT-II (CD45.1 + ) Tg CD4 + T cells. (lower) Frequency of PD-1 hi CXCR5 hi cells among OTREG-1 (CD45.2 + ) and OT-II (CD45.1 + ) Tg CD4 + T cells. All flow cytometry data were acquired from at least two independent experiments. Error bars show mean ± SD, P values were calculated using unpaired Student’s t -test, not significant(ns), * P <0.05, ** P <0.01, *** P <0.001, **** P <0.0001.

Journal: bioRxiv

Article Title: TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

doi: 10.64898/2026.02.12.705537

Figure Lengend Snippet: ( A ) Altered thymocyte development in OTREG-1 Tg mice. (left) Flow cytometry plots of CD4 and CD8 expression in thymocytes from 4–5-week-old WT and OTREG-1 Tg mice. (right) Quantification of DN (double-negative), DP (double-positive), CD4 SP (single-positive), and CD8 SP populations. Data are pooled from all mice. Female WT(n=9), Male WT(n=10), Female OTREG-1 Tg (n=10), Male OTREG-1 Tg (n=10). ( B ) Impaired thymic maturation of OTREG-1 Tg T cells. (left) CD24 and Qa-2 expression on TCRβ hi CD4 SP thymocytes. (right) Frequency of mature CD24 lo Qa-2 hi cells among TCRβ hi CD4 SP thymocytes. Female WT(n=9), Male WT(n=10), Female OTREG-1 Tg (n=10), Male OTREG-1 Tg (n=10). ( C ) Homeostatic proliferation of OTREG-1 Tg T cells. (left) Histograms showing proliferation (CFSE dilution) of splenic OTREG-1 Tg (n=4) and OT-II Tg (n=4) CD4 + T cells. (right) Quantification of divided cells at day 4 and day 7. ( D ) Competitive proliferation assay design. Naive CD4 + CD25 − CD44 lo CD62 hi T cells from CD45.2 + OTREG-1 Tg and CD45.1 + OT-II Tg mice were mixed 1:1, CFSE-labeled, and transferred into CD45.1 + CD45.2 + WT hosts. Recipients were immunized i.p. with PBS (n=2) or NP-OVA plus alum (n=11); donor cells were analyzed 3 days later. ( E ) Activation of OTREG-1 versus OT-II Tg T cells. Flow cytometry plots of CFSE dilution (proliferation) and CD44 expression in donor CD45.2 + OTREG-1 and CD45.1 + OT-II Tg CD4 + T cells. ( F ) T FH differentiation potential. Flow cytometry plots of PD-1 and CXCR5 expression on donor OTREG-1 and OT-II Tg CD4 + T cells. ( G ) Quantification of activated/proliferating T cells. (upper) Frequency of CFSE lo CD44 hi cells among OTREG-1 (CD45.2 + ) and OT-II (CD45.1 + ) Tg CD4 + T cells. (lower) Frequency of PD-1 hi CXCR5 hi cells among OTREG-1 (CD45.2 + ) and OT-II (CD45.1 + ) Tg CD4 + T cells. All flow cytometry data were acquired from at least two independent experiments. Error bars show mean ± SD, P values were calculated using unpaired Student’s t -test, not significant(ns), * P <0.05, ** P <0.01, *** P <0.001, **** P <0.0001.

Article Snippet: For footpad immunization, mice received 10 μg of alum-precipitated NP-OVA (Biosearch Technologies) as previously described ( ).

Techniques: Flow Cytometry, Expressing, Proliferation Assay, Labeling, Activation Assay

( A ) Experimental design for assessing the stability of OTREG-1 T reg cells. CD45.2 + CD4 + YFP + OTREG-1 Tg tT reg cells were sorted from CNS1-YFP-RFP OTREG-1 Tg mice and adoptively transferred into CD45.1 + WT recipients via tail vein injection. Mice were immunized i.p. with NP-OVA plus alum or PBS (control) the following day, and donor cells were analyzed by flow cytometry 7 days post-transfer. ( B ) Homeostasis of transferred tT reg cells. Frequency of donor OTREG-1 Tg tT reg cells (CD45.2 + ) among splenic CD4 + T cells in recipient mice. ( C ) Stability of transferred tT reg cells. Foxp3 and Thy1.1 expression in donor tT reg cells from recipient spleens. Numbers indicate gate frequencies. ( D ) T FR cells differentiation. PD-1 and CXCR5 expression on donor tT reg cells following immunization. The percentage of PD-1 hi CXCR5 hi Tfr cells is shown. ( E ) Foxp3 stability of T FR versus non-T FR cell populations. Foxp3 expression in OVA-specific PD-1 lo CXCR5 lo (non-T FR ) and PD-1 hi CXCR5 hi (T FR ) cells from immunized mice. ( F ) Antigen challenge protocol for OTREG-1 retrogenic mice. CNS1-YFP-RFP OTREG-1 retrogenic mice received NP-OVA plus alum immunizations at day 0 and day 14, with analysis performed 14 days after the second immunization. ( G ) Antigen-specific versus bystander activation. PD-1 and CXCR5 upregulation on NGFR + CD4 + Tconv cells and tT reg cells from retrogenic mice, comparing OVA-specific (NGFR + ) versus non-specific (NGFR - ) populations. ( H ) Foxp3 instability in T FR versus non-T FR cell subsets. (left) Flow cytometry analysis of Foxp3 expression in PD-1 lo CXCR5 lo and PD-1 hi CXCR5 hi cell populations gated on CD4 + CD45.1 + YFP + NGFR + cells. (right) Quantification of ex-tT reg cells (Foxp3 - Thy1.1 - ) in each subset. (B) to (E) shows pooled data from three independent experiments with PBS group (n=6) and NP-OVA group (n=11). (G) to (H) shows pooled data from three independent experiments (n=14). All flow cytometry data were acquired from at least two independent experiments. Error bars show mean ± SD, P values were calculated using paired (G to H) or unpaired (B to E) Student’s t -test, * P <0.05, ** P <0.01, *** P <0.001, **** P <0.0001.

Journal: bioRxiv

Article Title: TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

doi: 10.64898/2026.02.12.705537

Figure Lengend Snippet: ( A ) Experimental design for assessing the stability of OTREG-1 T reg cells. CD45.2 + CD4 + YFP + OTREG-1 Tg tT reg cells were sorted from CNS1-YFP-RFP OTREG-1 Tg mice and adoptively transferred into CD45.1 + WT recipients via tail vein injection. Mice were immunized i.p. with NP-OVA plus alum or PBS (control) the following day, and donor cells were analyzed by flow cytometry 7 days post-transfer. ( B ) Homeostasis of transferred tT reg cells. Frequency of donor OTREG-1 Tg tT reg cells (CD45.2 + ) among splenic CD4 + T cells in recipient mice. ( C ) Stability of transferred tT reg cells. Foxp3 and Thy1.1 expression in donor tT reg cells from recipient spleens. Numbers indicate gate frequencies. ( D ) T FR cells differentiation. PD-1 and CXCR5 expression on donor tT reg cells following immunization. The percentage of PD-1 hi CXCR5 hi Tfr cells is shown. ( E ) Foxp3 stability of T FR versus non-T FR cell populations. Foxp3 expression in OVA-specific PD-1 lo CXCR5 lo (non-T FR ) and PD-1 hi CXCR5 hi (T FR ) cells from immunized mice. ( F ) Antigen challenge protocol for OTREG-1 retrogenic mice. CNS1-YFP-RFP OTREG-1 retrogenic mice received NP-OVA plus alum immunizations at day 0 and day 14, with analysis performed 14 days after the second immunization. ( G ) Antigen-specific versus bystander activation. PD-1 and CXCR5 upregulation on NGFR + CD4 + Tconv cells and tT reg cells from retrogenic mice, comparing OVA-specific (NGFR + ) versus non-specific (NGFR - ) populations. ( H ) Foxp3 instability in T FR versus non-T FR cell subsets. (left) Flow cytometry analysis of Foxp3 expression in PD-1 lo CXCR5 lo and PD-1 hi CXCR5 hi cell populations gated on CD4 + CD45.1 + YFP + NGFR + cells. (right) Quantification of ex-tT reg cells (Foxp3 - Thy1.1 - ) in each subset. (B) to (E) shows pooled data from three independent experiments with PBS group (n=6) and NP-OVA group (n=11). (G) to (H) shows pooled data from three independent experiments (n=14). All flow cytometry data were acquired from at least two independent experiments. Error bars show mean ± SD, P values were calculated using paired (G to H) or unpaired (B to E) Student’s t -test, * P <0.05, ** P <0.01, *** P <0.001, **** P <0.0001.

Article Snippet: For footpad immunization, mice received 10 μg of alum-precipitated NP-OVA (Biosearch Technologies) as previously described ( ).

Techniques: Injection, Control, Flow Cytometry, Expressing, Activation Assay

Review

np ova (Biosearch Technologies Inc)

Structured Review

Images

1) Product Images from "Protocol for an in vivo CRISPR screen for germinal center B cells in mice using ecotropic retrovirus"

Related Articles

other:

Enzyme-linked Immunosorbent Assay:

Conjugation Assay:

Adjuvant:

Mouse Assay:

Immunofluorescence:

Similar Products

Image Search Results